Clinical Trials Logo

Prenatal Depression clinical trials

View clinical trials related to Prenatal Depression.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04414943 Completed - Clinical trials for Postpartum Depression

Low-dose S-ketamine in Women With Prenatal Depression

Start date: June 19, 2020
Phase: N/A
Study type: Interventional

Prenatal depression is an important risk factor of postpartum depression. Low-dose ketamine has been used for depression treatment. As a stereoisomer of ketamine, s-ketamine has similar effects to ketamine in anti-depression. We speculate that, for pregnant women with prenatal depression, low-dose s-ketamine infusion after childbirth may reduce the incidence of postpartum depression.

NCT ID: NCT03927378 Completed - Clinical trials for Postpartum Depression

Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression

Start date: June 19, 2020
Phase: N/A
Study type: Interventional

Prenatal depression is an important risk factor of postpartum depression. Low-dose ketamine has been used for depression treatment. As a stereoisomer of ketamine, s-ketamine has similar effects to ketamine in anti-depression. We speculate that, for pregnant women with prenatal depression, low-dose s-ketamine infusion after childbirth may reduce the incidence of postpartum depression.

NCT ID: NCT03393637 Completed - Preterm Birth Clinical Trials

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

M-O-M-S
Start date: December 1, 2017
Phase: N/A
Study type: Interventional

The M-O-M-S project evaluates the effectiveness of the M-O-M-S program for improving birth outcomes and maternal-infant attachment and role satisfaction in a large military sample.